Reports

Industry Research Reports

Global Microfluidic Chip in Biomedical Field Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Microfluidic Chip in Biomedical Field Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Medical Devices & Consumables

Published Date: 2026-03-26

Pages: 180 Pages

Report ld: 6321083

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Microfluidic Chip in Biomedical Field Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

9.8%

marketSize

Market Size,2032

USD 11,060

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 6,317 million
Market Forecast in 2032(Value)
US$ 11,060 million
CAGR
9.8%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5806 million in 2025 to US$ 11060 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Microfluidic chip in biomedical field is an integrated chip that integrates microscale channels and microfluidic technology, which is specially used in biomedical research, biological analysis and biological detection. In the biomedical field, microfluidic chips integrate or basically integrate the basic operating units such as sample preparation, reaction, separation, detection, cell culture, sorting, and lysis involved in fields such as chemistry and biology onto a chip of a few square centimeters or even smaller. A network is formed by microchannels, and controllable fluids run through the entire system to realize various functions of different laboratories such as conventional chemistry, biology, materials, and optics.

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Microfluidic Chip in Biomedical Field market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Agilent Technologies
  • Thermo Fisher Scientific
  • Illumina
  • Dolomite Microfluidics
  • Micronit
  • Bosch
  • microfluidic ChipShop
  • Fluigent
  • BioFluidix
  • WenHao Microfluidic Technology
  • TinKer BioTechnology
  • Dingxu Micro Control
  • Chongqing Chuangxin Biotechnology
  • Shenzhen Mindray Bio-Medical Electronics
  • Beijing Kerui Technology
  • ThinXXS Microtechnology
  • Dolomite Bio
  • Elveflow
  • uFluidix

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Silicon Material
  • Polymer Material

Segment by Application

  • Disease Diagnosis
  • Drug Development
  • Cell Culture and Analysis
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Microfluidic Chip in Biomedical Field study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves

marn_i1

Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application

marn_i1

Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers

marn_i1

Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers

marn_i1

Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas

marn_i1

Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges

marn_i1

Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments

marn_i1

Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles

marn_i1

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Microfluidic Chip in Biomedical Field: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Microfluidic Chip in Biomedical Field Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 Silicon Material

1.2.3 Polymer Material

1.3 Market Segmentation by Application

1.3.1 Global Microfluidic Chip in Biomedical Field Market Size by Application, 2021 vs 2025 vs 2032

1.3.2 Disease Diagnosis

1.3.3 Drug Development

1.3.4 Cell Culture and Analysis

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Microfluidic Chip in Biomedical Field Revenue Estimates and Forecasts (2021-2032)

2.2 Global Microfluidic Chip in Biomedical Field Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.3 Global Microfluidic Chip in Biomedical Field Sales Estimates and Forecasts (2021-2032)

2.4 Global Microfluidic Chip in Biomedical Field Sales by Region

2.4.1 Sales Comparison: 2021 vs 2025 vs 2032

2.4.2 Historical and Forecasted Sales by Region (2021-2032)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2021-2032)

muLu

3 Competitive Landscape

3.1 Global Microfluidic Chip in Biomedical Field Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2021-2026)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)

3.2 Global Microfluidic Chip in Biomedical Field Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)

3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)

3.3.2 Manufacturer-Level Price Trends (2021-2026)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Key Manufacturers Market Share by Product Type

3.5.1 Silicon Material: Market Share by Key Manufacturers

3.5.2 Polymer Material: Market Share by Key Manufacturers

3.6 Global Microfluidic Chip in Biomedical Field Market Concentration and Dynamics

3.6.1 Global Market Concentration

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Product Segmentation

4.1 Global Microfluidic Chip in Biomedical Field Sales Performance by Type

4.1.1 Global Microfluidic Chip in Biomedical Field Sales Volume by Type (2021-2032)

4.1.2 Global Microfluidic Chip in Biomedical Field Revenue by Type (2021-2032)

4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)

4.2 Product Technology Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Downstream Applications and Customers

5.1 Global Microfluidic Chip in Biomedical Field Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)

5.1.2 Global Sales Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Microfluidic Chip in Biomedical Field Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.2.2 Revenue-Based Market Share by Application (2021-2032)

5.3 Global Pricing Dynamics by Application (2021-2032)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2021-2032)

6.2 North America Key Manufacturers Sales Revenue in 2025

6.3 North America Microfluidic Chip in Biomedical Field Sales and Revenue by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Microfluidic Chip in Biomedical Field Market Size by Country

6.5.1 North America Revenue by Country

6.5.2 North America Sales Trends by Country

6.5.3 US

6.5.4 Canada

6.5.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2021-2032)

7.2 Europe Key Manufacturers Sales Revenue in 2025

7.3 Europe Microfluidic Chip in Biomedical Field Sales and Revenue by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Microfluidic Chip in Biomedical Field Market Size by Country

7.5.1 Europe Revenue by Country

7.5.2 Europe Sales Trends by Country

7.5.3 Germany

7.5.4 France

7.5.5 U.K.

7.5.6 Italy

7.5.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025

8.3 Asia-Pacific Microfluidic Chip in Biomedical Field Sales and Revenue by Application (2021-2032)

8.4 Asia-Pacific Microfluidic Chip in Biomedical Field Market Size by Region

8.4.1 Asia-Pacific Revenue by Region

8.4.2 Asia-Pacific Sales Trends by Region

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Southeast Asia

8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)

8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.7 China

8.8 Japan

8.9 South Korea

8.10 China Taiwan

8.11 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2021-2032)

9.2 Central and South America Key Manufacturers Sales Revenue in 2025

9.3 Central and South America Microfluidic Chip in Biomedical Field Sales and Revenue by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Microfluidic Chip in Biomedical Field Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025

10.3 Middle East and Africa Microfluidic Chip in Biomedical Field Sales and Revenue by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Microfluidic Chip in Biomedical Field Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Turkey

10.5.4 Egypt

10.5.5 South Africa

muLu

11 Corporate Profile

11.1 Agilent Technologies

11.1.1 Agilent Technologies Corporation Information

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.1.4 Agilent Technologies Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.1.5 Agilent Technologies Microfluidic Chip in Biomedical Field Sales by Product in 2025

11.1.6 Agilent Technologies Microfluidic Chip in Biomedical Field Sales by Application in 2025

11.1.7 Agilent Technologies Microfluidic Chip in Biomedical Field Sales by Geographic Area in 2025

11.1.8 Agilent Technologies Microfluidic Chip in Biomedical Field SWOT Analysis

11.1.9 Agilent Technologies Recent Developments

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Corporation Information

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.2.4 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.2.5 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales by Product in 2025

11.2.6 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales by Application in 2025

11.2.7 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales by Geographic Area in 2025

11.2.8 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field SWOT Analysis

11.2.9 Thermo Fisher Scientific Recent Developments

11.3 Illumina

11.3.1 Illumina Corporation Information

11.3.2 Illumina Business Overview

11.3.3 Illumina Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.3.4 Illumina Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.3.5 Illumina Microfluidic Chip in Biomedical Field Sales by Product in 2025

11.3.6 Illumina Microfluidic Chip in Biomedical Field Sales by Application in 2025

11.3.7 Illumina Microfluidic Chip in Biomedical Field Sales by Geographic Area in 2025

11.3.8 Illumina Microfluidic Chip in Biomedical Field SWOT Analysis

11.3.9 Illumina Recent Developments

11.4 Dolomite Microfluidics

11.4.1 Dolomite Microfluidics Corporation Information

11.4.2 Dolomite Microfluidics Business Overview

11.4.3 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.4.4 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.4.5 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales by Product in 2025

11.4.6 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales by Application in 2025

11.4.7 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales by Geographic Area in 2025

11.4.8 Dolomite Microfluidics Microfluidic Chip in Biomedical Field SWOT Analysis

11.4.9 Dolomite Microfluidics Recent Developments

11.5 Micronit

11.5.1 Micronit Corporation Information

11.5.2 Micronit Business Overview

11.5.3 Micronit Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.5.4 Micronit Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.5.5 Micronit Microfluidic Chip in Biomedical Field Sales by Product in 2025

11.5.6 Micronit Microfluidic Chip in Biomedical Field Sales by Application in 2025

11.5.7 Micronit Microfluidic Chip in Biomedical Field Sales by Geographic Area in 2025

11.5.8 Micronit Microfluidic Chip in Biomedical Field SWOT Analysis

11.5.9 Micronit Recent Developments

11.6 Bosch

11.6.1 Bosch Corporation Information

11.6.2 Bosch Business Overview

11.6.3 Bosch Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.6.4 Bosch Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.6.5 Bosch Recent Developments

11.7 microfluidic ChipShop

11.7.1 microfluidic ChipShop Corporation Information

11.7.2 microfluidic ChipShop Business Overview

11.7.3 microfluidic ChipShop Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.7.4 microfluidic ChipShop Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.7.5 microfluidic ChipShop Recent Developments

11.8 Fluigent

11.8.1 Fluigent Corporation Information

11.8.2 Fluigent Business Overview

11.8.3 Fluigent Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.8.4 Fluigent Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.8.5 Fluigent Recent Developments

11.9 BioFluidix

11.9.1 BioFluidix Corporation Information

11.9.2 BioFluidix Business Overview

11.9.3 BioFluidix Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.9.4 BioFluidix Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.9.5 BioFluidix Recent Developments

11.10 WenHao Microfluidic Technology

11.10.1 WenHao Microfluidic Technology Corporation Information

11.10.2 WenHao Microfluidic Technology Business Overview

11.10.3 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.10.4 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.10.5 WenHao Microfluidic Technology Recent Developments

11.11 TinKer BioTechnology

11.11.1 TinKer BioTechnology Corporation Information

11.11.2 TinKer BioTechnology Business Overview

11.11.3 TinKer BioTechnology Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.11.4 TinKer BioTechnology Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.11.5 TinKer BioTechnology Recent Developments

11.12 Dingxu Micro Control

11.12.1 Dingxu Micro Control Corporation Information

11.12.2 Dingxu Micro Control Business Overview

11.12.3 Dingxu Micro Control Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.12.4 Dingxu Micro Control Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.12.5 Dingxu Micro Control Recent Developments

11.13 Chongqing Chuangxin Biotechnology

11.13.1 Chongqing Chuangxin Biotechnology Corporation Information

11.13.2 Chongqing Chuangxin Biotechnology Business Overview

11.13.3 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.13.4 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.13.5 Chongqing Chuangxin Biotechnology Recent Developments

11.14 Shenzhen Mindray Bio-Medical Electronics

11.14.1 Shenzhen Mindray Bio-Medical Electronics Corporation Information

11.14.2 Shenzhen Mindray Bio-Medical Electronics Business Overview

11.14.3 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.14.4 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.14.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments

11.15 Beijing Kerui Technology

11.15.1 Beijing Kerui Technology Corporation Information

11.15.2 Beijing Kerui Technology Business Overview

11.15.3 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.15.4 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.15.5 Beijing Kerui Technology Recent Developments

11.16 ThinXXS Microtechnology

11.16.1 ThinXXS Microtechnology Corporation Information

11.16.2 ThinXXS Microtechnology Business Overview

11.16.3 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.16.4 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.16.5 ThinXXS Microtechnology Recent Developments

11.17 Dolomite Bio

11.17.1 Dolomite Bio Corporation Information

11.17.2 Dolomite Bio Business Overview

11.17.3 Dolomite Bio Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.17.4 Dolomite Bio Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.17.5 Dolomite Bio Recent Developments

11.18 Elveflow

11.18.1 Elveflow Corporation Information

11.18.2 Elveflow Business Overview

11.18.3 Elveflow Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.18.4 Elveflow Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.18.5 Elveflow Recent Developments

11.19 uFluidix

11.19.1 uFluidix Corporation Information

11.19.2 uFluidix Business Overview

11.19.3 uFluidix Microfluidic Chip in Biomedical Field Product Models, Descriptions and Specifications

11.19.4 uFluidix Microfluidic Chip in Biomedical Field Sales, Price, Revenue and Gross Margin (2021-2026)

11.19.5 uFluidix Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 Microfluidic Chip in Biomedical Field Industry Chain

12.2 Microfluidic Chip in Biomedical Field Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Microfluidic Chip in Biomedical Field Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2021-2032)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Microfluidic Chip in Biomedical Field Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Microfluidic Chip in Biomedical Field Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

13.4 Impact of U.S. Tariffs

muLu

14 Key Findings in the Global Microfluidic Chip in Biomedical Field Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Microfluidic Chip in Biomedical Field Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Microfluidic Chip in Biomedical Field Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Microfluidic Chip in Biomedical Field Revenue by Region (US$ Million), 2021-2026
Table 5. Global Microfluidic Chip in Biomedical Field Revenue by Region (US$ Million), 2027-2032
Table 6. Global Microfluidic Chip in Biomedical Field Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Pcs)
Table 7. Global Microfluidic Chip in Biomedical Field Sales by Region (K Pcs), 2021-2026
Table 8. Global Microfluidic Chip in Biomedical Field Sales by Region (K Pcs), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Microfluidic Chip in Biomedical Field Sales by Manufacturers (K Pcs), 2021-2026
Table 11. Global Microfluidic Chip in Biomedical Field Sales Share by Manufacturers (2021-2026)
Table 12. Global Microfluidic Chip in Biomedical Field Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Microfluidic Chip in Biomedical Field Revenue, 2025
Table 16. Global Microfluidic Chip in Biomedical Field Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Microfluidic Chip in Biomedical Field Average Selling Price (ASP) by Manufacturers (US$/Pc), 2021-2026
Table 18. Key Manufacturers Microfluidic Chip in Biomedical Field Manufacturing Base and Headquarters
Table 19. Global Microfluidic Chip in Biomedical Field Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Microfluidic Chip in Biomedical Field Sales Volume by Type (K Pcs), 2021-2026
Table 23. Global Microfluidic Chip in Biomedical Field Sales Volume by Type (K Pcs), 2027-2032
Table 24. Global Microfluidic Chip in Biomedical Field Revenue by Type (US$ Million), 2021-2026
Table 25. Global Microfluidic Chip in Biomedical Field Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Microfluidic Chip in Biomedical Field Sales by Application (K Pcs), 2021-2026
Table 28. Global Microfluidic Chip in Biomedical Field Sales by Application (K Pcs), 2027-2032
Table 29. Microfluidic Chip in Biomedical Field High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Microfluidic Chip in Biomedical Field Revenue by Application (US$ Million), 2021-2026
Table 31. Global Microfluidic Chip in Biomedical Field Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Microfluidic Chip in Biomedical Field Growth Accelerators and Market Barriers
Table 35. North America Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Microfluidic Chip in Biomedical Field Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Microfluidic Chip in Biomedical Field Growth Accelerators and Market Barriers
Table 38. Europe Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Microfluidic Chip in Biomedical Field Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Microfluidic Chip in Biomedical Field Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Microfluidic Chip in Biomedical Field Growth Accelerators and Market Barriers
Table 43. Southeast Asia Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Microfluidic Chip in Biomedical Field Investment Opportunities and Key Challenges
Table 45. Central and South America Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Microfluidic Chip in Biomedical Field Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Microfluidic Chip in Biomedical Field Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Agilent Technologies Corporation Information
Table 49. Agilent Technologies Description and Major Businesses
Table 50. Agilent Technologies Product Models, Descriptions and Specifications
Table 51. Agilent Technologies Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 52. Agilent Technologies Sales Value Proportion by Product in 2025
Table 53. Agilent Technologies Sales Value Proportion by Application in 2025
Table 54. Agilent Technologies Sales Value Proportion by Geographic Area in 2025
Table 55. Agilent Technologies Microfluidic Chip in Biomedical Field SWOT Analysis
Table 56. Agilent Technologies Recent Developments
Table 57. Thermo Fisher Scientific Corporation Information
Table 58. Thermo Fisher Scientific Description and Major Businesses
Table 59. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 60. Thermo Fisher Scientific Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 61. Thermo Fisher Scientific Sales Value Proportion by Product in 2025
Table 62. Thermo Fisher Scientific Sales Value Proportion by Application in 2025
Table 63. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2025
Table 64. Thermo Fisher Scientific Microfluidic Chip in Biomedical Field SWOT Analysis
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Illumina Corporation Information
Table 67. Illumina Description and Major Businesses
Table 68. Illumina Product Models, Descriptions and Specifications
Table 69. Illumina Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 70. Illumina Sales Value Proportion by Product in 2025
Table 71. Illumina Sales Value Proportion by Application in 2025
Table 72. Illumina Sales Value Proportion by Geographic Area in 2025
Table 73. Illumina Microfluidic Chip in Biomedical Field SWOT Analysis
Table 74. Illumina Recent Developments
Table 75. Dolomite Microfluidics Corporation Information
Table 76. Dolomite Microfluidics Description and Major Businesses
Table 77. Dolomite Microfluidics Product Models, Descriptions and Specifications
Table 78. Dolomite Microfluidics Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 79. Dolomite Microfluidics Sales Value Proportion by Product in 2025
Table 80. Dolomite Microfluidics Sales Value Proportion by Application in 2025
Table 81. Dolomite Microfluidics Sales Value Proportion by Geographic Area in 2025
Table 82. Dolomite Microfluidics Microfluidic Chip in Biomedical Field SWOT Analysis
Table 83. Dolomite Microfluidics Recent Developments
Table 84. Micronit Corporation Information
Table 85. Micronit Description and Major Businesses
Table 86. Micronit Product Models, Descriptions and Specifications
Table 87. Micronit Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 88. Micronit Sales Value Proportion by Product in 2025
Table 89. Micronit Sales Value Proportion by Application in 2025
Table 90. Micronit Sales Value Proportion by Geographic Area in 2025
Table 91. Micronit Microfluidic Chip in Biomedical Field SWOT Analysis
Table 92. Micronit Recent Developments
Table 93. Bosch Corporation Information
Table 94. Bosch Description and Major Businesses
Table 95. Bosch Product Models, Descriptions and Specifications
Table 96. Bosch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 97. Bosch Recent Developments
Table 98. microfluidic ChipShop Corporation Information
Table 99. microfluidic ChipShop Description and Major Businesses
Table 100. microfluidic ChipShop Product Models, Descriptions and Specifications
Table 101. microfluidic ChipShop Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 102. microfluidic ChipShop Recent Developments
Table 103. Fluigent Corporation Information
Table 104. Fluigent Description and Major Businesses
Table 105. Fluigent Product Models, Descriptions and Specifications
Table 106. Fluigent Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 107. Fluigent Recent Developments
Table 108. BioFluidix Corporation Information
Table 109. BioFluidix Description and Major Businesses
Table 110. BioFluidix Product Models, Descriptions and Specifications
Table 111. BioFluidix Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 112. BioFluidix Recent Developments
Table 113. WenHao Microfluidic Technology Corporation Information
Table 114. WenHao Microfluidic Technology Description and Major Businesses
Table 115. WenHao Microfluidic Technology Product Models, Descriptions and Specifications
Table 116. WenHao Microfluidic Technology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 117. WenHao Microfluidic Technology Recent Developments
Table 118. TinKer BioTechnology Corporation Information
Table 119. TinKer BioTechnology Description and Major Businesses
Table 120. TinKer BioTechnology Product Models, Descriptions and Specifications
Table 121. TinKer BioTechnology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 122. TinKer BioTechnology Recent Developments
Table 123. Dingxu Micro Control Corporation Information
Table 124. Dingxu Micro Control Description and Major Businesses
Table 125. Dingxu Micro Control Product Models, Descriptions and Specifications
Table 126. Dingxu Micro Control Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 127. Dingxu Micro Control Recent Developments
Table 128. Chongqing Chuangxin Biotechnology Corporation Information
Table 129. Chongqing Chuangxin Biotechnology Description and Major Businesses
Table 130. Chongqing Chuangxin Biotechnology Product Models, Descriptions and Specifications
Table 131. Chongqing Chuangxin Biotechnology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 132. Chongqing Chuangxin Biotechnology Recent Developments
Table 133. Shenzhen Mindray Bio-Medical Electronics Corporation Information
Table 134. Shenzhen Mindray Bio-Medical Electronics Description and Major Businesses
Table 135. Shenzhen Mindray Bio-Medical Electronics Product Models, Descriptions and Specifications
Table 136. Shenzhen Mindray Bio-Medical Electronics Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 137. Shenzhen Mindray Bio-Medical Electronics Recent Developments
Table 138. Beijing Kerui Technology Corporation Information
Table 139. Beijing Kerui Technology Description and Major Businesses
Table 140. Beijing Kerui Technology Product Models, Descriptions and Specifications
Table 141. Beijing Kerui Technology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 142. Beijing Kerui Technology Recent Developments
Table 143. ThinXXS Microtechnology Corporation Information
Table 144. ThinXXS Microtechnology Description and Major Businesses
Table 145. ThinXXS Microtechnology Product Models, Descriptions and Specifications
Table 146. ThinXXS Microtechnology Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 147. ThinXXS Microtechnology Recent Developments
Table 148. Dolomite Bio Corporation Information
Table 149. Dolomite Bio Description and Major Businesses
Table 150. Dolomite Bio Product Models, Descriptions and Specifications
Table 151. Dolomite Bio Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 152. Dolomite Bio Recent Developments
Table 153. Elveflow Corporation Information
Table 154. Elveflow Description and Major Businesses
Table 155. Elveflow Product Models, Descriptions and Specifications
Table 156. Elveflow Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 157. Elveflow Recent Developments
Table 158. uFluidix Corporation Information
Table 159. uFluidix Description and Major Businesses
Table 160. uFluidix Product Models, Descriptions and Specifications
Table 161. uFluidix Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 162. uFluidix Recent Developments
Table 163. Key Raw Materials Distribution
Table 164. Raw Materials Key Suppliers
Table 165. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 166. Milestones in Production Technology Evolution
Table 167. Distributors List
Table 168. Market Trends and Market Evolution
Table 169. Market Drivers and Opportunities
Table 170. Market Challenges, Risks, and Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Microfluidic Chip in Biomedical Field Product Picture
Figure 2. Global Microfluidic Chip in Biomedical Field Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Silicon Material Product Picture
Figure 4. Polymer Material Product Picture
Figure 5. Global Microfluidic Chip in Biomedical Field Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Disease Diagnosis
Figure 7. Drug Development
Figure 8. Cell Culture and Analysis
Figure 9. Other
Figure 10. Microfluidic Chip in Biomedical Field Report Years Considered
Figure 11. Global Microfluidic Chip in Biomedical Field Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 13. Global Microfluidic Chip in Biomedical Field Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Microfluidic Chip in Biomedical Field Sales (K Pcs), 2021-2032
Figure 16. Global Microfluidic Chip in Biomedical Field Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Pcs)
Figure 17. Global Microfluidic Chip in Biomedical Field Sales Market Share by Region (2021-2032)
Figure 18. Top 5 and Top 10 Manufacturers Microfluidic Chip in Biomedical Field Sales Volume Market Share in 2025
Figure 19. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share Ranking (2025)
Figure 20. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 21. Silicon Material Revenue-Based Market Share by Manufacturer in 2025
Figure 22. Polymer Material Revenue-Based Market Share by Manufacturer in 2025
Figure 23. Global Microfluidic Chip in Biomedical Field Sales Volume-Based Market Share by Type (2021-2032)
Figure 24. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share by Type (2021-2032)
Figure 25. Global Microfluidic Chip in Biomedical Field ASP by Type (US$/Pc), 2021-2032
Figure 26. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share (2021-2032)
Figure 27. Global Microfluidic Chip in Biomedical Field Sales Market Share by Application (2021-2032)
Figure 28. Global Microfluidic Chip in Biomedical Field Revenue-Based Market Share by Application (2021-2032)
Figure 29. Global Microfluidic Chip in Biomedical Field ASP by Application (US$/Pc), 2021-2032
Figure 30. North America Microfluidic Chip in Biomedical Field Sales YoY (K Pcs), 2021-2032
Figure 31. North America Microfluidic Chip in Biomedical Field Revenue YoY (US$ Million), 2021-2032
Figure 32. North America Top 5 Manufacturers Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) in 2025
Figure 33. North America Microfluidic Chip in Biomedical Field Sales Volume (K Pcs) by Application (2021-2032)
Figure 34. North America Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) by Application (2021-2032)
Figure 35. US Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 36. Canada Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 37. Mexico Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 38. Europe Microfluidic Chip in Biomedical Field Sales YoY (K Pcs), 2021-2032
Figure 39. Europe Microfluidic Chip in Biomedical Field Revenue YoY (US$ Million), 2021-2032
Figure 40. Europe Top 5 Manufacturers Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) in 2025
Figure 41. Europe Microfluidic Chip in Biomedical Field Sales Volume (K Pcs) by Application (2021-2032)
Figure 42. Europe Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) by Application (2021-2032)
Figure 43. Germany Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 44. France Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 45. U.K. Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 46. Italy Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 47. Russia Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 48. Asia-Pacific Microfluidic Chip in Biomedical Field Sales YoY (K Pcs), 2021-2032
Figure 49. Asia-Pacific Microfluidic Chip in Biomedical Field Revenue YoY (US$ Million), 2021-2032
Figure 50. Asia-Pacific Top 8 Manufacturers Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) in 2025
Figure 51. Asia-Pacific Microfluidic Chip in Biomedical Field Sales Volume (K Pcs) by Application (2021-2032)
Figure 52. Asia-Pacific Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) by Application (2021-2032)
Figure 53. Indonesia Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 54. Japan Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 55. South Korea Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 56. China Taiwan Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 57. India Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 58. Central and South America Microfluidic Chip in Biomedical Field Sales YoY (K Pcs), 2021-2032
Figure 59. Central and South America Microfluidic Chip in Biomedical Field Revenue YoY (US$ Million), 2021-2032
Figure 60. Central and South America Top 5 Manufacturers Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) in 2025
Figure 61. Central and South America Microfluidic Chip in Biomedical Field Sales Volume (K Pcs) by Application (2021-2032)
Figure 62. Central and South America Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) by Application (2021-2032)
Figure 63. Brazil Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 64. Argentina Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 65. Middle East, and Africa Microfluidic Chip in Biomedical Field Sales YoY (K Pcs), 2021-2032
Figure 66. Middle East and Africa Microfluidic Chip in Biomedical Field Revenue YoY (US$ Million), 2021-2032
Figure 67. Middle East and Africa Top 5 Manufacturers Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) in 2025
Figure 68. Middle East and Africa Microfluidic Chip in Biomedical Field Sales Volume (K Pcs) by Application (2021-2032)
Figure 69. Middle East and Africa Microfluidic Chip in Biomedical Field Sales Revenue (US$ Million) by Application (2021-2032)
Figure 70. GCC Countries Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 71. Turkey Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 72. Egypt Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 73. South Africa Microfluidic Chip in Biomedical Field Revenue (US$ Million), 2021-2032
Figure 74. Microfluidic Chip in Biomedical Field Industry Chain Mapping
Figure 75. Regional Microfluidic Chip in Biomedical Field Manufacturing Base Distribution (%)
Figure 76. Global Microfluidic Chip in Biomedical Field Production Market Share by Region (2021-2032)
Figure 77. Microfluidic Chip in Biomedical Field Production Process
Figure 78. Regional Microfluidic Chip in Biomedical Field Production Cost Structure
Figure 79. Channels of Distribution (Direct Vs Distribution)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Microfluidic Chip in Biomedical Field in 2032?zhanKai
The global market size of Microfluidic Chip in Biomedical Field in 2032 was 11060 Million USD.
Which region is expected to have the highest market share?shouQi
What was the global market size of Microfluidic Chip in Biomedical Field in 2026?shouQi
Which companies rank high in the global Microfluidic Chip in Biomedical Field market?shouQi
What is the annual compound growth rate of the global Microfluidic Chip in Biomedical Field market size from 2026 to 2032?shouQi
den_biaoTiZhungShi

Related Reports

Global Microfluidic Chip in Biomedical Field Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Medical Devices & Consumables

Published Date: 2026-03-26

Pages: 180 Pages

Report ld: 6321083

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now